TheNewswireWed, 17 Jun 2026 13:25:00 GMTGLP-1 "Arms Race" Intensifies as the Addressable Markets Continue to ExpandLEXX+7.89%
TheNewswireTue, 09 Jun 2026 13:25:00 GMTLexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway.LEXX+7.89%
TheNewswireWed, 03 Jun 2026 13:25:00 GMTLexaria Attending the BIO International Convention, as part of a Broader Business Development ProgramLEXX+7.89%
TheNewswireThu, 07 May 2026 13:25:00 GMTLexaria Bioscience Releases Second Episode of Investor Video SeriesLEXX+7.89%
TheNewswireThu, 23 Apr 2026 13:05:00 GMTLexaria Launches New Study to Examine Next-Generation GLP-1 DrugsLEXX+7.89%
TheNewswireTue, 21 Apr 2026 13:10:00 GMTLexaria Expects Oral GLP-1 Pills to Generate Billions in New Industry SalesLEXX+7.89%
TheNewswireWed, 15 Apr 2026 13:10:00 GMTLexaria's New Animal Study Aims to Expand Valuable Intellectual PropertyLEXX+7.89%
TheNewswireTue, 07 Apr 2026 13:10:00 GMTLexaria Applauds Eli Lilly's Foundayo(TM) Drug ApprovalLEXX+7.89%
TheNewswireThu, 26 Mar 2026 13:20:00 GMTLexaria's Robust Patent Portfolio Continues to GrowLEXX+7.89%
